Baxter International Inc. News Headlines

BAX 
$72.66
*  
0.44
0.6%
Get BAX Alerts
*Delayed - data as of Sep. 19, 2014 15:36 ET  -  Find a broker to begin trading BAX now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    BAX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

NeoStem: Timing Is Everything
9/19/2014 1:14:00 PM - Seeking Alpha

Ultimate Sustainable Dividend Portfolio - September 2014 Update - Moving Ahead
9/18/2014 7:59:00 PM - Seeking Alpha

Can A Successful Dividend Portfolio Be Assembled In 2014? - Part 3
9/18/2014 2:34:00 PM - Seeking Alpha

Seeking High-Quality Companies With Sales And Dividend Growth, And A Reasonable Price
9/17/2014 2:27:00 PM - Seeking Alpha

Recent Price Decline Creates An Attractive Entry Point For Halozyme
9/16/2014 10:35:00 AM - Seeking Alpha

Investors Should Exercise Caution With REVO Biologics IPO
9/16/2014 8:22:00 AM - Seeking Alpha

Update: Baxter On A Hot Streak - FDA Approves Rixubis
9/15/2014 3:02:00 PM - Seeking Alpha

Baxter and Halozyme Therapeutics Get FDA Approval - Analyst Blog
9/15/2014 1:50:00 PM - Zacks.com

Sector Update: Health Care Stocks Mixed; Baxter International, Halo Therapeutics Declining Despite Regulatory OKs for Hemophilia Drug
9/15/2014 1:22:13 PM - MT Newswires

Sector Update: Health Care
9/15/2014 1:19:18 PM - MT Newswires

FDA OKs Baxter's RIXUBIS For Treatment Of Children With Hemophilia B
9/15/2014 9:11:00 AM - RTT News

Sector Update: Health-Care Shares Flat Pre-Market
9/15/2014 8:04:53 AM - MT Newswires

Sector Update: Health Care
9/15/2014 8:04:38 AM - MT Newswires

Update: Baxter Receives Approval For Hyqvia - Growth Prospects Improve
9/14/2014 3:41:00 AM - Seeking Alpha

FDA Okays Baxter's Hyqvia To Treat Adults With Primary Immunodeficiency
9/12/2014 8:18:00 PM - RTT News

Momenta Gains on Purchase of Autoimmune Antibodies - Analyst Blog
9/11/2014 5:45:00 PM - Zacks.com

Wall Street Reverts To Caution
9/11/2014 6:34:00 AM - RTT News

Baxter Spinoff Drug Business to Be Named Baxalta
9/10/2014 5:55:00 PM - Dow Jones Business News

Baxter Reveals Name Of New Global Biopharmaceutical Company
9/10/2014 4:48:00 PM - RTT News

Medtronic: Benefits Of Covidien Acquisition Not Enough To Make It A Buy
9/10/2014 1:34:00 PM - Seeking Alpha

Is It Time to Buy Hospira, Inc.'s Stock?
9/8/2014 6:40:03 PM - Motley Fool

Baxter International To Present At Morgan Stanley Conference; Webcast At 1:25 PM
9/8/2014 12:25:00 PM - RTT News

Why Baxter International Offers Great Reward for Minimal Risk
9/8/2014 6:00:00 AM - TheStreet

Halozyme's PEGPH20 Program Gains Fast Track Designation - Analyst Blog
9/5/2014 5:00:00 PM - Zacks.com

Becton, Dickinson and Company (BDX) Ex-Dividend Date Scheduled for September 05, 2014
9/4/2014 9:00:02 AM - NASDAQ.com News